By Sandy Tammisetty, VP of the Veeva Services Practice Group at Conexus Solutions. Artificial intelligence (AI) is no longer a future concept in clinical trials. It is already influencing how clinical data is reviewed, monitored, and analysed, particularly as trials become more complex and data volumes continue to grow. From anomaly detection to advanced analytics, AI is increasingly positioned […]
To read this content in full, you need to login.
Not yet a DDW member? Join now for FREE – it takes less than 2 minutes!